PLAVIX for Coronary artery disease: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 13 adverse event reports in the FDA FAERS database where PLAVIX was used for Coronary artery disease.
Most Reported Side Effects for PLAVIX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Gastrointestinal haemorrhage | 723 | 33.8% | 35 | 45 |
| Ulcer haemorrhage | 400 | 18.7% | 22 | 10 |
| Haemorrhage | 362 | 16.9% | 33 | 14 |
| Multiple injuries | 320 | 15.0% | 26 | 1 |
| Cerebral haemorrhage | 130 | 6.1% | 38 | 12 |
| Cerebrovascular accident | 96 | 4.5% | 15 | 14 |
| Myocardial infarction | 84 | 3.9% | 10 | 12 |
| Anaemia | 43 | 2.0% | 1 | 38 |
| Death | 41 | 1.9% | 41 | 3 |
| Dyspnoea | 28 | 1.3% | 1 | 16 |
| Thrombotic thrombocytopenic purpura | 27 | 1.3% | 3 | 1 |
| Nausea | 25 | 1.2% | 0 | 9 |
| Asthenia | 23 | 1.1% | 2 | 14 |
| Dizziness | 23 | 1.1% | 1 | 13 |
| Epistaxis | 20 | 0.9% | 0 | 10 |
Other Indications for PLAVIX
Product used for unknown indication (839)
Stent placement (68)
Prophylaxis (64)
Cerebrovascular accident (37)
Coronary arterial stent insertion (31)
Thrombosis prophylaxis (30)
Myocardial infarction (27)
Acute coronary syndrome (18)
Atrial fibrillation (14)
Transient ischaemic attack (14)
Other Drugs Used for Coronary artery disease
ASPIRIN (2,758)
CLOPIDOGREL BISULFATE (1,584)
EVOLOCUMAB (1,266)
ATORVASTATIN (891)
RIVAROXABAN (847)
DILTIAZEM (664)
ROSUVASTATIN (600)
TICAGRELOR (520)
QUINAPRIL (511)
AMLODIPINE (486)